CLARITY MEDICAL: Hong Kong Court Rejects Shareholder Lawsuit in Full

Bulletin Express
04/02

Clarity Medical Group Holding Limited announced that the High Court of Hong Kong has dismissed in its entirety the Originating Summons (HCMP 1627/2025) filed by shareholder Tse Wai Ip. The ruling, delivered at a hearing on 2 April 2026, strikes out all reliefs sought by the plaintiff.

The Court indicated that detailed written reasons will be handed down in due course. No further legal or financial implications were disclosed in the announcement.

As at 2 April 2026, Clarity Medical’s Board consists of one executive director, three non-executive directors and four independent non-executive directors, led by Executive Director and Chief Executive Officer Jiang Bo.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10